Merit Medical Systems, Inc. · NASDAQ:MMSI

Merit Medical Systems — Q2 2016 Earnings Presentation

11 slides from Merit Medical Systems's earnings presentation, Jul 27, 2016

  1. Slide 1: 2nd Quarter 2016 Results

    1 2nd Quarter 2016 Results FRED LAMPROPOULOS Chairman & CEO BERNARD BIRKETT CFO

  2. Slide 2: Disclosure Regarding Forward-Looking Statements

    2 DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes “forward-looking statements” as defined within applicable securities laws and regulations. All statements in this presentation, other than statements of historical fact, are “forward-looking statements”, including projectio

  3. Slide 3: Financial Summary Non-GAAP

    3 Financial Summary Non-GAAP 2016 YTD 2015 YTD Q2 2016 Q2 2015 Revenue (Constant Currency) $291.7M $267.7M $151.7M $138.1M Revenue (Reported) $289.1M $267.7M $151.1M $138.1M Gross Margin 46.1% 45.5% 46.4% 46.1% Net Income $19.8M $18.8M $11.5M $10.9M EPS $0.44 $0.42 $0.26 $0.25

  4. Slide 4: Financial Summary GAAP

    4 Financial Summary GAAP 2016 YTD 2015 YTD Q2 2016 Q2 2015 Revenue $289.1M $267.7M $151.1M $138.1M Gross Margin 43.9% 43.4% 44.3% 44.1% Net Income $11.6M $12.6M $7.3M $7.4M EPS $0.26 $0.28 $0.16 $0.17

  5. Slide 5: Sales by Category Q2 2016

    5 Sales by Category Q2 2016 US Direct 46.3% OEM 13.8% Endotek 3.7% International 20.0% EMEA 16.3%

  6. Slide 6: Q2 2016 Revenue Growth in Constant Currency Compared to Q2 2015

    6 Q2 2016 Revenue Growth in Constant Currency Compared to Q2 2015 0% 5% 10% 15% 20% 25% US Direct OEM Endotek International EMEA 10.3% 2.3% 4.8% 21.1% 5.3%

  7. Slide 7: Q2 2016 Highlights

    7 Q2 2016 Highlights • Transferred production of HeRO®Graft product line to Utah • FDA and CE approval of Corvocet™ Biopsy System • Ramped up catheter capacity in Pearland, Texas • Negotiated acquisition of DFINE, Inc. (closed July 6, 2016) • Canada office and warehouse operational • Mexico facility

  8. Slide 8: 2016 Growth Drivers

    8 2016 Growth Drivers • New Products - HeRO® Graft - Corvocet™ Biopsy Device - SwiftNINJA® Steerable Microcatheter - Pedal Access - Micropuncture - Centesis Catheters - Amplatz Guide Wires - 40 ATM BasixTouch™ Inflation Device - Prelude® SNAP Hydrophilic - Wire Guided & Pulmonary Balloons • Wholesal

  9. Slide 9: 2016 Guidance

    9 2016 Guidance Revenues $603.5M - $613.5M Gross Margin GAAP 44.5% - 45.5% Gross Margin Non-GAAP 46.5% - 47.5% EPS GAAP $0.74 - $0.80 EPS Non-GAAP $0.97 - $1.03

  10. Slide 10: Disciplined, customer-focused enterprise

    10 1 2 3 4 Disciplined, customer-focused enterprise Guided by strong core values to globally address unmet or underserved healthcare needs Target high-growth, high-return opportunities Through understanding, innovating, and delivering in peripheral, cardiac, OEM, and endoscopy business lines Optimiz

  11. Slide 11: 11

    11

Merit Medical Systems — Q2 2016 Earnings Presentation on 6ix